(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 4.88% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Bruker's revenue in 2026 is $3,436,500,000.On average, 18 Wall Street analysts forecast BRKR's revenue for 2026 to be $555,904,701,000, with the lowest BRKR revenue forecast at $532,615,155,750, and the highest BRKR revenue forecast at $574,779,888,000. On average, 18 Wall Street analysts forecast BRKR's revenue for 2027 to be $576,910,957,500, with the lowest BRKR revenue forecast at $542,509,407,000, and the highest BRKR revenue forecast at $607,202,588,250.
In 2028, BRKR is forecast to generate $604,919,299,500 in revenue, with the lowest revenue forecast at $565,798,952,250 and the highest revenue forecast at $650,585,074,500.